Stock screener

EVMN

Conviction 28HealthcareScan · Thu, Sep 24, 2026
Hammer

Evommune, Inc. (EVMN) closed at $8.81 (+0.40%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 28, -72.1% from its 52-week high, -49.1% year to date. Sector: Healthcare · Biotechnology.

EVMN$8.81+0.40%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
Vol MA14 953.69K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Evommune, Inc.Biotechnologywww.evommune.com ↗
Price8.81
Change+0.40%
Gap-1.14%
Rel volume1.92×
Avg volume788.5K
Avg $ vol8.4M
SMA 2010.95
SMA 5012.12
SMA 20019.26
Price vs 50-27.36%
Price vs 200-54.29%
MA stackbearish
50/200 cross—
Supertrenddown · 10.66
RSI (14)28
MACD hist-0.17
MACD cross—
Stoch %K / %D11 / 7
ADX (14)35
+DI / −DI11 / 38
RSI divergence—
MACD divergence—
ATR %8.39%
ADR %6.11%
52w high31.57
52w low8.77
From 52w high-72.11%
Above 52w low+0.40%
New 52w highNo
SqueezeOff
Bollinger width56.71%
%B0.15
Donchian pos9.06%
Donchian high14.18
Donchian low8.27
AVWAP (52w high)19.25
vs AVWAP high-54.25%
AVWAP (52w low)8.66
vs AVWAP low+1.73%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d1.92×
Avg vol (14d)953.68K
Avg vol (20d)788.5K
Avg $ vol (20d)8.4M
Market cap319.55M
RS Rating—
RS 3m (vs SPY)-68.00%
RS 6m (vs SPY)-78.75%
RS line new highNo
Trend template—
Technical rank4.7
1 week-6.03%
1 month-36.15%
3 months-63.51%
6 months-61.93%
1 year—
YTD-49.13%
P/E-4.64
P/B1.15
P/S24.58
P/FCF-4.17
EPS-11.22
Div yield—
ROE-24.81%
ROA-22.81%
Debt/Eq—
Current11.68
EV/EBITDA-3.23
Gross margin—
Net margin-529.77%
Rev growth85.71%
EPS growth-3.09%
Price target24.00
Target upside172.57%
Analyst ratingBuy
Institutional102.66%
Ent. value259.52M
Revenue0
Net income-32.25M
Gross profit—
Free cash flow-76.68M
IndustryBiotechnology
ExchangeNYSE
Shares out36.02M
Employees48
ListedThu, Nov 6, 2025
Free float10.05M
Float %31.9%
Short interest4.36M
Days to cover11.6d
Short volume24.4%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.89 vs −$0.68
Last surprise-30.9% miss
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank4.7 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EVMN

All disclosures →
No recent disclosed trades by Congress in EVMN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EVMN · open-market 2 buys · 3 sells

InsiderSideShares
Carver Kyle
Chief Financial Officer · Common Stock · 2026-07-08
Buy1K
KIRSCH ARTHUR S
Director · Common Stock · 2026-07-07
Buy10K
MCGRAW BENJAMIN F III
Director · Stock Option (Right to buy) · 2026-06-02
Grant15.67K
Cohen David E
Director · Common Stock · 2026-06-02
Sell5.46K
Cohen David E
Director · Common Stock · 2026-06-02
Sell600
Cohen David E
Director · Stock Option (Right to buy) · 2026-06-02
Grant15.67K
KIRSCH ARTHUR S
Director · Stock Option (Right to buy) · 2026-06-02
Grant15.67K
Patel Jeegar Pravinkumar
Chief Scientific Officer · Common Stock · 2026-06-01
Sell16.69K
Patel Jeegar Pravinkumar
Chief Scientific Officer · Employee Stock Option (Right to Buy) · 2026-06-01
Exercise13.51K
Patel Jeegar Pravinkumar
Chief Scientific Officer · Common Stock · 2026-06-01
Exercise13.51K

SEC filings

EDGAR filings in EVMN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.